nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—POR—Doxorubicin—kidney cancer	0.347	0.415	CbGbCtD
Benzphetamine—CYP3A4—Everolimus—kidney cancer	0.109	0.13	CbGbCtD
Benzphetamine—CYP3A4—Temsirolimus—kidney cancer	0.0736	0.088	CbGbCtD
Benzphetamine—CYP2B6—Sorafenib—kidney cancer	0.073	0.0873	CbGbCtD
Benzphetamine—CYP2B6—Doxorubicin—kidney cancer	0.0443	0.0529	CbGbCtD
Benzphetamine—CYP3A4—Pazopanib—kidney cancer	0.0387	0.0462	CbGbCtD
Benzphetamine—CYP3A4—Erlotinib—kidney cancer	0.0276	0.033	CbGbCtD
Benzphetamine—CYP3A4—Paclitaxel—kidney cancer	0.0252	0.0302	CbGbCtD
Benzphetamine—CYP3A4—Sorafenib—kidney cancer	0.0224	0.0268	CbGbCtD
Benzphetamine—CYP3A4—Vinblastine—kidney cancer	0.0221	0.0265	CbGbCtD
Benzphetamine—CYP3A4—Vincristine—kidney cancer	0.0218	0.026	CbGbCtD
Benzphetamine—CYP3A4—Sunitinib—kidney cancer	0.0182	0.0217	CbGbCtD
Benzphetamine—CYP3A4—Doxorubicin—kidney cancer	0.0136	0.0163	CbGbCtD
Benzphetamine—Cardiomyopathy—Sunitinib—kidney cancer	0.00526	0.0444	CcSEcCtD
Benzphetamine—Cardiomyopathy—Paclitaxel—kidney cancer	0.00353	0.0298	CcSEcCtD
Benzphetamine—Cardiomyopathy—Capecitabine—kidney cancer	0.0029	0.0245	CcSEcCtD
Benzphetamine—Cardiomyopathy—Doxorubicin—kidney cancer	0.00187	0.0158	CcSEcCtD
Benzphetamine—Anorexia—Temsirolimus—kidney cancer	0.00147	0.0124	CcSEcCtD
Benzphetamine—Hyperhidrosis—Pazopanib—kidney cancer	0.00141	0.0119	CcSEcCtD
Benzphetamine—Insomnia—Temsirolimus—kidney cancer	0.0014	0.0118	CcSEcCtD
Benzphetamine—Anorexia—Pazopanib—kidney cancer	0.00139	0.0117	CcSEcCtD
Benzphetamine—Decreased appetite—Temsirolimus—kidney cancer	0.00134	0.0113	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00133	0.0113	CcSEcCtD
Benzphetamine—Tremor—Everolimus—kidney cancer	0.00132	0.0111	CcSEcCtD
Benzphetamine—Insomnia—Pazopanib—kidney cancer	0.00132	0.0111	CcSEcCtD
Benzphetamine—Agitation—Everolimus—kidney cancer	0.00129	0.0109	CcSEcCtD
Benzphetamine—Dyspepsia—Pazopanib—kidney cancer	0.00128	0.0108	CcSEcCtD
Benzphetamine—Decreased appetite—Pazopanib—kidney cancer	0.00126	0.0107	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00126	0.0106	CcSEcCtD
Benzphetamine—Palpitations—Everolimus—kidney cancer	0.00124	0.0105	CcSEcCtD
Benzphetamine—Sweating—Vincristine—kidney cancer	0.00122	0.0103	CcSEcCtD
Benzphetamine—Sweating—Gemcitabine—kidney cancer	0.00116	0.00978	CcSEcCtD
Benzphetamine—Hypersensitivity—Temsirolimus—kidney cancer	0.00114	0.00962	CcSEcCtD
Benzphetamine—Tachycardia—Everolimus—kidney cancer	0.00112	0.00947	CcSEcCtD
Benzphetamine—Hyperhidrosis—Everolimus—kidney cancer	0.00111	0.00939	CcSEcCtD
Benzphetamine—Anorexia—Vinblastine—kidney cancer	0.0011	0.00929	CcSEcCtD
Benzphetamine—Anorexia—Everolimus—kidney cancer	0.00109	0.00925	CcSEcCtD
Benzphetamine—Trimethaphan—BCHE—kidney cancer	0.00106	0.154	CrCbGaD
Benzphetamine—Diarrhoea—Temsirolimus—kidney cancer	0.00106	0.00893	CcSEcCtD
Benzphetamine—Anorexia—Erlotinib—kidney cancer	0.00106	0.00893	CcSEcCtD
Benzphetamine—Insomnia—Everolimus—kidney cancer	0.00104	0.00878	CcSEcCtD
Benzphetamine—Dizziness—Temsirolimus—kidney cancer	0.00102	0.00863	CcSEcCtD
Benzphetamine—Dyspepsia—Everolimus—kidney cancer	0.00101	0.00855	CcSEcCtD
Benzphetamine—Insomnia—Erlotinib—kidney cancer	0.001	0.00847	CcSEcCtD
Benzphetamine—Decreased appetite—Vinblastine—kidney cancer	0.001	0.00847	CcSEcCtD
Benzphetamine—Decreased appetite—Everolimus—kidney cancer	0.000999	0.00844	CcSEcCtD
Benzphetamine—Diarrhoea—Pazopanib—kidney cancer	0.000995	0.00841	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Everolimus—kidney cancer	0.000992	0.00838	CcSEcCtD
Benzphetamine—Dyspepsia—Erlotinib—kidney cancer	0.000976	0.00825	CcSEcCtD
Benzphetamine—Headache—Temsirolimus—kidney cancer	0.000967	0.00818	CcSEcCtD
Benzphetamine—Decreased appetite—Erlotinib—kidney cancer	0.000963	0.00814	CcSEcCtD
Benzphetamine—Dizziness—Pazopanib—kidney cancer	0.000962	0.00813	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000957	0.00809	CcSEcCtD
Benzphetamine—Anorexia—Sorafenib—kidney cancer	0.00095	0.00803	CcSEcCtD
Benzphetamine—Nausea—Temsirolimus—kidney cancer	0.000917	0.00775	CcSEcCtD
Benzphetamine—Anorexia—Sunitinib—kidney cancer	0.000915	0.00773	CcSEcCtD
Benzphetamine—Agitation—Vincristine—kidney cancer	0.000914	0.00772	CcSEcCtD
Benzphetamine—Headache—Pazopanib—kidney cancer	0.000911	0.0077	CcSEcCtD
Benzphetamine—Dyspepsia—Sorafenib—kidney cancer	0.000878	0.00742	CcSEcCtD
Benzphetamine—Insomnia—Sunitinib—kidney cancer	0.000868	0.00733	CcSEcCtD
Benzphetamine—Decreased appetite—Sorafenib—kidney cancer	0.000867	0.00733	CcSEcCtD
Benzphetamine—Anorexia—Dactinomycin—kidney cancer	0.000866	0.00732	CcSEcCtD
Benzphetamine—Nausea—Pazopanib—kidney cancer	0.000864	0.0073	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000861	0.00728	CcSEcCtD
Benzphetamine—Hypersensitivity—Vinblastine—kidney cancer	0.00085	0.00718	CcSEcCtD
Benzphetamine—Hypersensitivity—Everolimus—kidney cancer	0.000846	0.00715	CcSEcCtD
Benzphetamine—Dyspepsia—Sunitinib—kidney cancer	0.000845	0.00714	CcSEcCtD
Benzphetamine—Decreased appetite—Sunitinib—kidney cancer	0.000834	0.00705	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000828	0.007	CcSEcCtD
Benzphetamine—Urticaria—Sorafenib—kidney cancer	0.000792	0.00669	CcSEcCtD
Benzphetamine—Decreased appetite—Dactinomycin—kidney cancer	0.00079	0.00667	CcSEcCtD
Benzphetamine—Diarrhoea—Vinblastine—kidney cancer	0.000789	0.00667	CcSEcCtD
Benzphetamine—Oxaprozin—PTGS1—kidney cancer	0.000786	0.114	CrCbGaD
Benzphetamine—Diarrhoea—Everolimus—kidney cancer	0.000786	0.00664	CcSEcCtD
Benzphetamine—Hyperhidrosis—Vincristine—kidney cancer	0.000785	0.00663	CcSEcCtD
Benzphetamine—Anorexia—Vincristine—kidney cancer	0.000774	0.00654	CcSEcCtD
Benzphetamine—Dizziness—Vinblastine—kidney cancer	0.000763	0.00644	CcSEcCtD
Benzphetamine—Dizziness—Everolimus—kidney cancer	0.00076	0.00642	CcSEcCtD
Benzphetamine—Diarrhoea—Erlotinib—kidney cancer	0.000758	0.00641	CcSEcCtD
Benzphetamine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000744	0.00629	CcSEcCtD
Benzphetamine—Tremor—Paclitaxel—kidney cancer	0.00074	0.00625	CcSEcCtD
Benzphetamine—Hypersensitivity—Sorafenib—kidney cancer	0.000735	0.00621	CcSEcCtD
Benzphetamine—Insomnia—Vincristine—kidney cancer	0.000734	0.0062	CcSEcCtD
Benzphetamine—Anorexia—Gemcitabine—kidney cancer	0.000734	0.0062	CcSEcCtD
Benzphetamine—Dizziness—Erlotinib—kidney cancer	0.000733	0.00619	CcSEcCtD
Benzphetamine—Agitation—Paclitaxel—kidney cancer	0.000726	0.00613	CcSEcCtD
Benzphetamine—Headache—Vinblastine—kidney cancer	0.000722	0.00611	CcSEcCtD
Benzphetamine—Headache—Everolimus—kidney cancer	0.00072	0.00608	CcSEcCtD
Benzphetamine—Hypersensitivity—Sunitinib—kidney cancer	0.000707	0.00597	CcSEcCtD
Benzphetamine—Decreased appetite—Vincristine—kidney cancer	0.000705	0.00596	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000701	0.00592	CcSEcCtD
Benzphetamine—Palpitations—Paclitaxel—kidney cancer	0.000698	0.0059	CcSEcCtD
Benzphetamine—Insomnia—Gemcitabine—kidney cancer	0.000696	0.00588	CcSEcCtD
Benzphetamine—Headache—Erlotinib—kidney cancer	0.000694	0.00587	CcSEcCtD
Benzphetamine—Nausea—Vinblastine—kidney cancer	0.000685	0.00579	CcSEcCtD
Benzphetamine—Nausea—Everolimus—kidney cancer	0.000682	0.00577	CcSEcCtD
Benzphetamine—Diarrhoea—Sorafenib—kidney cancer	0.000682	0.00577	CcSEcCtD
Benzphetamine—Ethopropazine—BCHE—kidney cancer	0.000674	0.0982	CrCbGaD
Benzphetamine—Decreased appetite—Gemcitabine—kidney cancer	0.000669	0.00566	CcSEcCtD
Benzphetamine—Hypersensitivity—Dactinomycin—kidney cancer	0.000669	0.00566	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000665	0.00562	CcSEcCtD
Benzphetamine—Dizziness—Sorafenib—kidney cancer	0.000659	0.00557	CcSEcCtD
Benzphetamine—Nausea—Erlotinib—kidney cancer	0.000658	0.00556	CcSEcCtD
Benzphetamine—Diarrhoea—Sunitinib—kidney cancer	0.000656	0.00555	CcSEcCtD
Benzphetamine—Dizziness—Sunitinib—kidney cancer	0.000634	0.00536	CcSEcCtD
Benzphetamine—Toremifene—CYP1A1—kidney cancer	0.00063	0.0918	CrCbGaD
Benzphetamine—Tachycardia—Paclitaxel—kidney cancer	0.000629	0.00532	CcSEcCtD
Benzphetamine—Headache—Sorafenib—kidney cancer	0.000625	0.00528	CcSEcCtD
Benzphetamine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000623	0.00527	CcSEcCtD
Benzphetamine—Diarrhoea—Dactinomycin—kidney cancer	0.000621	0.00525	CcSEcCtD
Benzphetamine—Anorexia—Paclitaxel—kidney cancer	0.000614	0.00519	CcSEcCtD
Benzphetamine—Tremor—Capecitabine—kidney cancer	0.000607	0.00513	CcSEcCtD
Benzphetamine—Headache—Sunitinib—kidney cancer	0.000601	0.00508	CcSEcCtD
Benzphetamine—Hypersensitivity—Vincristine—kidney cancer	0.000598	0.00505	CcSEcCtD
Benzphetamine—Nausea—Sorafenib—kidney cancer	0.000592	0.00501	CcSEcCtD
Benzphetamine—Insomnia—Paclitaxel—kidney cancer	0.000583	0.00493	CcSEcCtD
Benzphetamine—Palpitations—Capecitabine—kidney cancer	0.000573	0.00484	CcSEcCtD
Benzphetamine—Nausea—Sunitinib—kidney cancer	0.00057	0.00482	CcSEcCtD
Benzphetamine—Dyspepsia—Paclitaxel—kidney cancer	0.000567	0.0048	CcSEcCtD
Benzphetamine—Decreased appetite—Paclitaxel—kidney cancer	0.00056	0.00474	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000556	0.0047	CcSEcCtD
Benzphetamine—Diarrhoea—Vincristine—kidney cancer	0.000555	0.00469	CcSEcCtD
Benzphetamine—Nausea—Dactinomycin—kidney cancer	0.00054	0.00456	CcSEcCtD
Benzphetamine—Dizziness—Vincristine—kidney cancer	0.000537	0.00454	CcSEcCtD
Benzphetamine—Diarrhoea—Gemcitabine—kidney cancer	0.000527	0.00445	CcSEcCtD
Benzphetamine—Phenylbutazone—PTGS1—kidney cancer	0.00052	0.0757	CrCbGaD
Benzphetamine—Tachycardia—Capecitabine—kidney cancer	0.000516	0.00436	CcSEcCtD
Benzphetamine—Sweating—Doxorubicin—kidney cancer	0.000513	0.00433	CcSEcCtD
Benzphetamine—Urticaria—Paclitaxel—kidney cancer	0.000512	0.00433	CcSEcCtD
Benzphetamine—Hyperhidrosis—Capecitabine—kidney cancer	0.000511	0.00432	CcSEcCtD
Benzphetamine—Headache—Vincristine—kidney cancer	0.000508	0.0043	CcSEcCtD
Benzphetamine—Anorexia—Capecitabine—kidney cancer	0.000504	0.00426	CcSEcCtD
Benzphetamine—Headache—Gemcitabine—kidney cancer	0.000482	0.00408	CcSEcCtD
Benzphetamine—Nausea—Vincristine—kidney cancer	0.000482	0.00407	CcSEcCtD
Benzphetamine—Insomnia—Capecitabine—kidney cancer	0.000478	0.00404	CcSEcCtD
Benzphetamine—Hypersensitivity—Paclitaxel—kidney cancer	0.000475	0.00401	CcSEcCtD
Benzphetamine—Dyspepsia—Capecitabine—kidney cancer	0.000466	0.00394	CcSEcCtD
Benzphetamine—Decreased appetite—Capecitabine—kidney cancer	0.00046	0.00389	CcSEcCtD
Benzphetamine—Nausea—Gemcitabine—kidney cancer	0.000457	0.00386	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000457	0.00386	CcSEcCtD
Benzphetamine—Oxaprozin—PTGS2—kidney cancer	0.000449	0.0654	CrCbGaD
Benzphetamine—Diarrhoea—Paclitaxel—kidney cancer	0.000441	0.00373	CcSEcCtD
Benzphetamine—Dizziness—Paclitaxel—kidney cancer	0.000426	0.0036	CcSEcCtD
Benzphetamine—Urticaria—Capecitabine—kidney cancer	0.00042	0.00355	CcSEcCtD
Benzphetamine—Headache—Paclitaxel—kidney cancer	0.000404	0.00341	CcSEcCtD
Benzphetamine—Hypersensitivity—Capecitabine—kidney cancer	0.00039	0.00329	CcSEcCtD
Benzphetamine—Agitation—Doxorubicin—kidney cancer	0.000384	0.00324	CcSEcCtD
Benzphetamine—Nausea—Paclitaxel—kidney cancer	0.000383	0.00324	CcSEcCtD
Benzphetamine—Palpitations—Doxorubicin—kidney cancer	0.000369	0.00312	CcSEcCtD
Benzphetamine—Diarrhoea—Capecitabine—kidney cancer	0.000362	0.00306	CcSEcCtD
Benzphetamine—Dizziness—Capecitabine—kidney cancer	0.00035	0.00296	CcSEcCtD
Benzphetamine—Toremifene—ABCB1—kidney cancer	0.000335	0.0488	CrCbGaD
Benzphetamine—Tachycardia—Doxorubicin—kidney cancer	0.000333	0.00281	CcSEcCtD
Benzphetamine—Headache—Capecitabine—kidney cancer	0.000331	0.0028	CcSEcCtD
Benzphetamine—Hyperhidrosis—Doxorubicin—kidney cancer	0.00033	0.00279	CcSEcCtD
Benzphetamine—Anorexia—Doxorubicin—kidney cancer	0.000325	0.00275	CcSEcCtD
Benzphetamine—Nausea—Capecitabine—kidney cancer	0.000314	0.00266	CcSEcCtD
Benzphetamine—Insomnia—Doxorubicin—kidney cancer	0.000308	0.00261	CcSEcCtD
Benzphetamine—Dyspepsia—Doxorubicin—kidney cancer	0.0003	0.00254	CcSEcCtD
Benzphetamine—Phenylbutazone—PTGS2—kidney cancer	0.000297	0.0433	CrCbGaD
Benzphetamine—Decreased appetite—Doxorubicin—kidney cancer	0.000296	0.00251	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000294	0.00249	CcSEcCtD
Benzphetamine—Diphenhydramine—PTGS1—kidney cancer	0.000283	0.0412	CrCbGaD
Benzphetamine—Urticaria—Doxorubicin—kidney cancer	0.000271	0.00229	CcSEcCtD
Benzphetamine—Tamoxifen—CYP1A1—kidney cancer	0.000252	0.0367	CrCbGaD
Benzphetamine—Hypersensitivity—Doxorubicin—kidney cancer	0.000251	0.00212	CcSEcCtD
Benzphetamine—Propafenone—ABCB1—kidney cancer	0.000236	0.0344	CrCbGaD
Benzphetamine—Diarrhoea—Doxorubicin—kidney cancer	0.000233	0.00197	CcSEcCtD
Benzphetamine—Dizziness—Doxorubicin—kidney cancer	0.000225	0.00191	CcSEcCtD
Benzphetamine—Selegiline—ABCB1—kidney cancer	0.000224	0.0327	CrCbGaD
Benzphetamine—Headache—Doxorubicin—kidney cancer	0.000214	0.00181	CcSEcCtD
Benzphetamine—Bepridil—ABCB1—kidney cancer	0.00021	0.0306	CrCbGaD
Benzphetamine—Nausea—Doxorubicin—kidney cancer	0.000203	0.00171	CcSEcCtD
Benzphetamine—Fentanyl—ABCB1—kidney cancer	0.000193	0.0282	CrCbGaD
Benzphetamine—Phenytoin—ABCB1—kidney cancer	0.000175	0.0256	CrCbGaD
Benzphetamine—Trimipramine—ABCB1—kidney cancer	0.00014	0.0204	CrCbGaD
Benzphetamine—Promethazine—ABCB1—kidney cancer	0.000135	0.0196	CrCbGaD
Benzphetamine—Tamoxifen—ABCB1—kidney cancer	0.000134	0.0195	CrCbGaD
Benzphetamine—Methadone—ABCB1—kidney cancer	0.000133	0.0193	CrCbGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKAP13—kidney cancer	3.67e-05	0.000961	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—FH—kidney cancer	3.65e-05	0.000957	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APRT—kidney cancer	3.65e-05	0.000957	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IFNA1—kidney cancer	3.62e-05	0.000949	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKAP13—kidney cancer	3.59e-05	0.00094	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	3.57e-05	0.000935	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.56e-05	0.000932	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GPC3—kidney cancer	3.44e-05	0.0009	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AMER1—kidney cancer	3.43e-05	0.000898	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APRT—kidney cancer	3.43e-05	0.000897	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—FH—kidney cancer	3.43e-05	0.000897	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.38e-05	0.000885	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IFNA2—kidney cancer	3.37e-05	0.000884	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—ITPR2—kidney cancer	3.36e-05	0.00088	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.35e-05	0.000878	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CA2—kidney cancer	3.34e-05	0.000875	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKAP13—kidney cancer	3.33e-05	0.000873	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ALAD—kidney cancer	3.26e-05	0.000853	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—RAF1—kidney cancer	3.24e-05	0.000849	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GPC3—kidney cancer	3.22e-05	0.000844	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	3.2e-05	0.000839	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ST3GAL2—kidney cancer	3.18e-05	0.000833	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.15e-05	0.000826	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CA2—kidney cancer	3.13e-05	0.000821	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—ITPR2—kidney cancer	3.12e-05	0.000818	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.11e-05	0.000815	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ALDH1A1—kidney cancer	3.11e-05	0.000814	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GPC3—kidney cancer	3.09e-05	0.00081	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CER1—kidney cancer	3.09e-05	0.00081	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ALAD—kidney cancer	3.05e-05	0.0008	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—ITPR2—kidney cancer	3.05e-05	0.000799	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IGF2—kidney cancer	3.04e-05	0.000796	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ST3GAL2—kidney cancer	2.98e-05	0.000781	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SLC5A3—kidney cancer	2.98e-05	0.00078	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PGK1—kidney cancer	2.98e-05	0.00078	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	2.98e-05	0.00078	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—LDHB—kidney cancer	2.92e-05	0.000765	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ALDH1A1—kidney cancer	2.91e-05	0.000763	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.91e-05	0.000762	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.9e-05	0.000759	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GPC3—kidney cancer	2.87e-05	0.000753	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CER1—kidney cancer	2.87e-05	0.000753	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.86e-05	0.000749	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—ITPR2—kidney cancer	2.83e-05	0.000742	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—ANXA1—kidney cancer	2.81e-05	0.000737	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PGK1—kidney cancer	2.79e-05	0.000732	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC5A3—kidney cancer	2.79e-05	0.000732	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.75e-05	0.000719	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—LDHB—kidney cancer	2.74e-05	0.000717	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.71e-05	0.00071	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SFRP2—kidney cancer	2.63e-05	0.000689	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—ANXA1—kidney cancer	2.62e-05	0.000685	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	2.57e-05	0.000674	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—MAPK1—kidney cancer	2.57e-05	0.000673	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—ANXA1—kidney cancer	2.56e-05	0.00067	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CA9—kidney cancer	2.53e-05	0.000663	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.47e-05	0.000647	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	2.45e-05	0.000641	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SFRP2—kidney cancer	2.44e-05	0.00064	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—POMC—kidney cancer	2.44e-05	0.000639	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ACY1—kidney cancer	2.42e-05	0.000633	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—ANXA1—kidney cancer	2.37e-05	0.000622	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CA9—kidney cancer	2.37e-05	0.000622	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—PIK3CA—kidney cancer	2.37e-05	0.000622	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.34e-05	0.000612	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	2.31e-05	0.000605	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.27e-05	0.000595	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—POMC—kidney cancer	2.27e-05	0.000594	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.22e-05	0.000583	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CRABP1—kidney cancer	2.15e-05	0.000564	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	2.12e-05	0.000556	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKAP13—kidney cancer	2.12e-05	0.000555	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CASP2—kidney cancer	2.12e-05	0.000555	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PDHB—kidney cancer	2.05e-05	0.000538	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—POMC—kidney cancer	2.05e-05	0.000536	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CRABP1—kidney cancer	2.02e-05	0.000529	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—RAF1—kidney cancer	2.01e-05	0.000527	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ITPR2—kidney cancer	2e-05	0.000524	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP2—kidney cancer	1.97e-05	0.000516	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKAP13—kidney cancer	1.97e-05	0.000516	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GRB7—kidney cancer	1.94e-05	0.000508	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.93e-05	0.000506	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.93e-05	0.000506	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ITPR2—kidney cancer	1.88e-05	0.000492	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ACHE—kidney cancer	1.83e-05	0.000478	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTT1—kidney cancer	1.83e-05	0.000478	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ITPR2—kidney cancer	1.8e-05	0.000472	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GRB7—kidney cancer	1.8e-05	0.000472	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SCARB1—kidney cancer	1.73e-05	0.000453	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTT1—kidney cancer	1.71e-05	0.000448	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ACHE—kidney cancer	1.71e-05	0.000448	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS1—kidney cancer	1.71e-05	0.000448	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PSMD7—kidney cancer	1.68e-05	0.00044	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.67e-05	0.000439	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPAT—kidney cancer	1.67e-05	0.000439	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ITPR2—kidney cancer	1.67e-05	0.000439	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—RAF1—kidney cancer	1.67e-05	0.000438	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CTNNA1—kidney cancer	1.63e-05	0.000428	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HSPB1—kidney cancer	1.62e-05	0.000425	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EIF4EBP1—kidney cancer	1.62e-05	0.000425	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SCARB1—kidney cancer	1.62e-05	0.000424	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS1—kidney cancer	1.6e-05	0.00042	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—BCHE—kidney cancer	1.59e-05	0.000417	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PSMD7—kidney cancer	1.57e-05	0.000412	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SLC5A5—kidney cancer	1.57e-05	0.000412	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—FH—kidney cancer	1.56e-05	0.000408	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APRT—kidney cancer	1.56e-05	0.000408	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CTNNA1—kidney cancer	1.52e-05	0.000398	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SLC2A1—kidney cancer	1.52e-05	0.000397	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ANXA1—kidney cancer	1.51e-05	0.000396	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TSC1—kidney cancer	1.51e-05	0.000396	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PSMD7—kidney cancer	1.51e-05	0.000396	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EIF4EBP1—kidney cancer	1.51e-05	0.000395	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HSPB1—kidney cancer	1.51e-05	0.000395	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IL2—kidney cancer	1.5e-05	0.000393	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—BCHE—kidney cancer	1.49e-05	0.000391	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.47e-05	0.000386	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GPC3—kidney cancer	1.46e-05	0.000383	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FLT1—kidney cancer	1.46e-05	0.000383	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CA2—kidney cancer	1.42e-05	0.000373	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.42e-05	0.000373	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TSC1—kidney cancer	1.4e-05	0.000368	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PSMD7—kidney cancer	1.4e-05	0.000368	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ANXA1—kidney cancer	1.4e-05	0.000368	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALAD—kidney cancer	1.39e-05	0.000363	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—POMC—kidney cancer	1.38e-05	0.000361	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FLT1—kidney cancer	1.36e-05	0.000356	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—JUNB—kidney cancer	1.36e-05	0.000355	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PAK1—kidney cancer	1.36e-05	0.000355	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.35e-05	0.000355	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.32e-05	0.000347	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—POMC—kidney cancer	1.28e-05	0.000336	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—kidney cancer	1.27e-05	0.000334	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PGK1—kidney cancer	1.27e-05	0.000332	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.27e-05	0.000332	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTP1—kidney cancer	1.27e-05	0.000332	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—JUNB—kidney cancer	1.26e-05	0.00033	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PAK1—kidney cancer	1.26e-05	0.00033	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—POMC—kidney cancer	1.25e-05	0.000328	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LDHB—kidney cancer	1.24e-05	0.000326	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—MAPK3—kidney cancer	1.2e-05	0.000316	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ABCB1—kidney cancer	1.2e-05	0.000314	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTP1—kidney cancer	1.19e-05	0.000311	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—POMC—kidney cancer	1.16e-05	0.000305	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTM1—kidney cancer	1.16e-05	0.000305	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—MAPK1—kidney cancer	1.15e-05	0.0003	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ABCB1—kidney cancer	1.12e-05	0.000294	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF2—kidney cancer	1.11e-05	0.00029	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CDKN2B—kidney cancer	1.1e-05	0.000289	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP1A1—kidney cancer	1.1e-05	0.000289	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTM1—kidney cancer	1.09e-05	0.000286	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—KRAS—kidney cancer	1.08e-05	0.000284	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CA9—kidney cancer	1.08e-05	0.000283	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1R—kidney cancer	1.07e-05	0.000281	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.03e-05	0.000271	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—RAF1—kidney cancer	1.03e-05	0.00027	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF2—kidney cancer	1.03e-05	0.00027	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CDKN2B—kidney cancer	1.03e-05	0.000269	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—IL2—kidney cancer	1.02e-05	0.000267	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1R—kidney cancer	9.96e-06	0.000261	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PIK3CA—kidney cancer	9.95e-06	0.000261	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TP53—kidney cancer	9.62e-06	0.000252	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—RAF1—kidney cancer	9.59e-06	0.000251	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—IL2—kidney cancer	9.47e-06	0.000248	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL2—kidney cancer	9.26e-06	0.000243	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CRABP1—kidney cancer	9.18e-06	0.00024	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HIF1A—kidney cancer	8.82e-06	0.000231	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TSC2—kidney cancer	8.8e-06	0.000231	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL2—kidney cancer	8.6e-06	0.000225	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ITPR2—kidney cancer	8.53e-06	0.000223	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KDR—kidney cancer	8.44e-06	0.000221	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—POMC—kidney cancer	8.22e-06	0.000215	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HIF1A—kidney cancer	8.2e-06	0.000215	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TSC2—kidney cancer	8.18e-06	0.000214	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KDR—kidney cancer	7.84e-06	0.000205	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTT1—kidney cancer	7.78e-06	0.000204	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ACHE—kidney cancer	7.78e-06	0.000204	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KIT—kidney cancer	7.77e-06	0.000204	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APC—kidney cancer	7.77e-06	0.000204	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—POMC—kidney cancer	7.71e-06	0.000202	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MAPK3—kidney cancer	7.44e-06	0.000195	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—POMC—kidney cancer	7.4e-06	0.000194	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SCARB1—kidney cancer	7.36e-06	0.000193	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—BRAF—kidney cancer	7.3e-06	0.000191	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS1—kidney cancer	7.29e-06	0.000191	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KIT—kidney cancer	7.22e-06	0.000189	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APC—kidney cancer	7.22e-06	0.000189	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PSMD7—kidney cancer	7.15e-06	0.000187	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	7.08e-06	0.000186	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	6.92e-06	0.000181	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—POMC—kidney cancer	6.87e-06	0.00018	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—BRAF—kidney cancer	6.79e-06	0.000178	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—BCHE—kidney cancer	6.78e-06	0.000178	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	6.77e-06	0.000177	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.69e-06	0.000175	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	6.69e-06	0.000175	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	6.58e-06	0.000172	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS2—kidney cancer	6.56e-06	0.000172	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC2A1—kidney cancer	6.46e-06	0.000169	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	6.29e-06	0.000165	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	6.21e-06	0.000163	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS2—kidney cancer	6.15e-06	0.000161	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	6.15e-06	0.000161	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RAF1—kidney cancer	6.1e-06	0.00016	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RELA—kidney cancer	6.07e-06	0.000159	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	6.03e-06	0.000158	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MTOR—kidney cancer	5.95e-06	0.000156	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTEN—kidney cancer	5.72e-06	0.00015	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	5.71e-06	0.00015	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RAF1—kidney cancer	5.67e-06	0.000148	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RELA—kidney cancer	5.64e-06	0.000148	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	5.61e-06	0.000147	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	5.59e-06	0.000146	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MTOR—kidney cancer	5.53e-06	0.000145	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL2—kidney cancer	5.47e-06	0.000143	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTP1—kidney cancer	5.39e-06	0.000141	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTEN—kidney cancer	5.36e-06	0.00014	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	5.33e-06	0.00014	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—JUN—kidney cancer	5.32e-06	0.000139	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	5.28e-06	0.000138	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	5.19e-06	0.000136	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	5.15e-06	0.000135	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCB1—kidney cancer	5.1e-06	0.000134	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL2—kidney cancer	5.08e-06	0.000133	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTM1—kidney cancer	4.95e-06	0.00013	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCND1—kidney cancer	4.95e-06	0.00013	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—JUN—kidney cancer	4.94e-06	0.000129	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	4.91e-06	0.000128	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTEN—kidney cancer	4.78e-06	0.000125	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.7e-06	0.000123	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	4.65e-06	0.000122	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	4.4e-06	0.000115	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	4.32e-06	0.000113	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MYC—kidney cancer	4.28e-06	0.000112	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	4.18e-06	0.00011	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	4.09e-06	0.000107	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CA—kidney cancer	4.03e-06	0.000106	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MYC—kidney cancer	3.97e-06	0.000104	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	3.95e-06	0.000104	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	3.89e-06	0.000102	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CA—kidney cancer	3.78e-06	9.91e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KRAS—kidney cancer	3.67e-06	9.62e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	3.63e-06	9.51e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TP53—kidney cancer	3.51e-06	9.2e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—POMC—kidney cancer	3.5e-06	9.17e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	3.37e-06	8.84e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TP53—kidney cancer	3.26e-06	8.55e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS2—kidney cancer	2.79e-06	7.32e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTEN—kidney cancer	2.44e-06	6.38e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.72e-06	4.5e-05	CbGpPWpGaD
